Not applicableStudy completedNCT02909283What this trial is testingSickle Cell Anemia and Cerebral Microcirculation : Multimodal ExplorationWho this might be right forSickle Cell Disease Imagine Institute 64
Not applicableStudy completedNCT04041180What this trial is testingImpact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .Who this might be right forSickle Cell DiseasePediatric Centre Hospitalier Régional d'Orléans 25
Testing effectiveness (Phase 2)Study completedNCT00496262What this trial is testingHuman Fibrinogen - PharmacokineticsWho this might be right forFibrinogen Deficiency CSL Behring 15
Testing effectiveness (Phase 2)Study completedNCT00453388What this trial is testingFludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaWho this might be right forAcute Myeloid Leukemia in Remissionde Novo Myelodysplastic SyndromeFanconi Anemia+1 more Fred Hutchinson Cancer Center 6
Not applicableStudy completedNCT04168788What this trial is testingPharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALLWho this might be right forHepatic Veno-Occlusive DiseaseNephroblastomaAcute Lymphoblastic Leukemia University Hospital, Angers 85
Testing effectiveness (Phase 2)Study completedNCT00469859What this trial is testingLestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 14
Not applicableUnknownNCT03989986What this trial is testingIPeer2Peer Program for Youth With Sickle Cell DiseaseWho this might be right forSickle Cell Disease The Hospital for Sick Children 28
Testing effectiveness (Phase 2)Study completedNCT01044186What this trial is testingA Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe ToxicityWho this might be right forTransfusional Iron Overload Novartis Pharmaceuticals 30
Not applicableEnded earlyNCT02569359What this trial is testingEfficacy and Safety of Shea Nut Oil in Hemophilic ArthropathyWho this might be right forHemophiliaHemophilic Arthropathy Tri-Service General Hospital (TSGH) 6
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05734196What this trial is testingThe ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 DeficiencyWho this might be right forEctonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy+2 more Inozyme Pharma 16
Large-scale testing (Phase 3)Study completedNCT02250573What this trial is testingAn Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing SurgeryWho this might be right forHaemophilia B Bio Products Laboratory
Not applicableStudy completedNCT04417673What this trial is testingLiving With Sickle Cell Disease in the COVID-19 PandemicWho this might be right forIsolationAnxietyHealth Care Utilization+2 more National Human Genome Research Institute (NHGRI) 186
Early research (Phase 1)UnknownNCT02888223What this trial is testingPharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia AWho this might be right forHemophilia A Sinocelltech Ltd. 16
Not applicableActive Not RecruitingNCT03047746What this trial is testingUnrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMFWho this might be right forAcquired Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaInherited Bone Marrow Failure Syndromes Children's Hospital of Philadelphia 50
Not applicableLooking for participantsNCT04728841What this trial is testingGene Therapy for Chinese Hemophilia AWho this might be right forHemophilia AGene Therapy Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Not applicableStudy completedNCT00735540What this trial is testingClinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsWho this might be right forAnorexiaThalassemiaSickle Cell Anemia+2 more HaEmek Medical Center, Israel 1,389
Not applicableStudy completedNCT00495638What this trial is testingPulmonary Hypertension, Hypoxia and Sickle Cell DiseaseWho this might be right forChuvash PolycythemiaCerebrovascular DiseasePulmonary Hypertension+1 more National Heart, Lung, and Blood Institute (NHLBI) 29
Large-scale testing (Phase 3)UnknownNCT05487976What this trial is testingClinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With InhibitorWho this might be right forHemophilia AHemophilia B Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50